Practice Management
Researchers found the oral antiviral drug nirmatrelvir/ritonavir (Paxlovid) is safe for kids as young as age 6 with mild/moderate COVID-19 who were at increased risk for severe disease, as published in Pediatrics. Of the in 75 children in the international study, 81% had 1 risk factor for severe COVID-19, most commonly obesity (49%) or chronic lung disease (40%). Additionally, 56% were unvaccinated. Children aged 6–17 years who weighed 40 kg or more received 300 mg …
Read More
The Centers for Disease Control and Prevention (CDC) found low use of COVID-19 antiviral drugs among individuals age 65 and older, even though it’s a population at high risk of severe illness and COVID-19–related hospitalization, according to the recent Morbidity and Mortality Weekly Report. Researchers examined cases in outpatient settings with a positive SARS-CoV-2 test result or COVID-19 diagnosis during June 1, 2023–September 30, 2025. A total of 482,456 patient encounters with a COVID-19 diagnosis …
Read More
Vapocoolant and Digital Nerve Blocks Dosing Dexamethasone in Pediatric Asthma Infant Clean-Catch Urine Contamination Antibiotic-Associated Diarrhea in Children Treating Acute Diverticulitis Torus Wrist Fractures in Children Efficacy of Antiviral Treatment in COVID-19 Vapocoolant for Pain Reduction in Digital Nerve Blocks Take-home point: Application of vapocoolant prior to digital nerve blocking can reduce pain associated with skin puncture and local anesthetic infiltration. Citation: Selvi F, Bedel C, Akçimen M. Evaluation of vapocoolant spray effect on pain …
Read More